On June 19, 2017, Massachusetts governor Charlie Baker announced a plan to invest up to $500 million in the state s life-science industry. The five-year plan proposes strategic investments in public infrastructure, R&D, workforce training and education, and includes up to $295 million in capOriginal Article
You may also like
Ariane de Ganck
Jasper Therapeutics merges with Kira Pharmaceuticals
Lilly to acquire AtaiBeckley in deal worth $2.8bn
Camena Bioscience appoints Gregory McGuinness as CEO
New €25 Million BioReliance Testing Facility Opens...
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
